Resumen
In this study we used immunohistochemistry and two-dimensional fingerprinting of oxidatively modified proteins (two-dimensional Oxyblot) together to investigate protein carbonyl formation in the Alzheimer's disease brain. Increased protein oxidation was detected in sections from the hippocampus and parahippocampal gyrus, superior and middle temporal gyri of six Alzheimer's disease and six age-matched control human subjects, but not in the cerebellum. In two brain regions severely affected by Alzheimer's disease pathology, prominent protein carbonyl immunoreactivity was localized in the cytoplasm of neurons without visual pathomorphological changes and degenerating neurons, suggesting that intracellular proteins might be significantly affected by oxidative modifications. Following two-dimensional electrophoresis the positions of some individual proteins were identified using specific antibodies, and immunoblot analysis for protein carbonyls was performed. These studies demonstrated the presence of protein carbonyl immunoreactivity in β-tubulin, β-actin and creatine kinase BB in Alzheimer's disease and control brain extracts. Protein carbonyls were undetectable in spots matching glial fibrillary acidic protein and tau isoforms. Specific protein carbonyl levels in β-actin and creatine kinase BB were significantly higher in Alzheimer's disease than in control brain extract. β-Tubulin did not demonstrate a significant increase in specific protein carbonyl content in Alzheimer's disease brains. We suggest that oxidative stress-induced injury may involve the selective modification of different intracellular proteins, including key enzymes and structural proteins, which precedes and may lead to the neurofibrillary degeneration of neurons in the Alzheimer's disease brain.
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 373-383 |
| Número de páginas | 11 |
| Publicación | Neuroscience |
| Volumen | 103 |
| N.º | 2 |
| DOI | |
| Estado | Published - mar 14 2001 |
Nota bibliográfica
Funding Information:This work was supported by NIH grants 5P01 AG05119, 5P50 AG05144, and grants from the Abercrombie Foundation and the Kleberg Foundation. The authors thank Dianna Tudor and Ela Patel for technical assistance, Jane Meara and Paula Thomason for assistance in manuscript preparation, and Cecil Runyons for subject demographic data. The authors also thank Elan Pharmaceutical for the gift of antibodies.
Financiación
This work was supported by NIH grants 5P01 AG05119, 5P50 AG05144, and grants from the Abercrombie Foundation and the Kleberg Foundation. The authors thank Dianna Tudor and Ela Patel for technical assistance, Jane Meara and Paula Thomason for assistance in manuscript preparation, and Cecil Runyons for subject demographic data. The authors also thank Elan Pharmaceutical for the gift of antibodies.
| Financiadores | Número del financiador |
|---|---|
| National Institutes of Health (NIH) | 5P01 AG05119 |
| National Institute on Aging | P50AG005144 |
| Abercrombie Foundation | |
| Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation |
ODS de las Naciones Unidas
Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible
-
Good health and well being
ASJC Scopus subject areas
- General Neuroscience
Huella
Profundice en los temas de investigación de 'Protein oxidation in the brain in Alzheimer's disease'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver